WEKO3
アイテム
{"_buckets": {"deposit": "fb7eeab6-a52f-4ab8-814b-4e496f5ad792"}, "_deposit": {"created_by": 1, "id": "47015", "owners": [1], "pid": {"revision_id": 0, "type": "depid", "value": "47015"}, "status": "published"}, "_oai": {"id": "oai:repo.qst.go.jp:00047015", "sets": ["1"]}, "author_link": ["469378", "469379", "469380"], "item_8_biblio_info_7": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2013-10", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "2", "bibliographicPageEnd": "147", "bibliographicPageStart": "146", "bibliographicVolumeNumber": "16", "bibliographic_titles": [{"bibliographic_title": "Hellenic Journal of Nuclear Medicine"}]}]}, "item_8_description_5": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "Treatment of recurrent prostate cancer (PC) after radical prostatectomy is based on the site of recurrent disease [1-3]. In a previous study, we showed that carbon-11 acetate positron emission tomography (AC PET) demonstrated marked uptake in 27/46 of PC patients in recurrence after radical prostatectomy\n(RP), while serum PSA was higher than 3.0ng/mL [4]. In the present paper we studied 11 patients with PC following RP, who had no clinical signs of recurrence, with PSA levels of\u003e1.0 or 1.0-3.0ng/mL and under recent hormone treatment. ", "subitem_description_type": "Abstract"}]}, "item_8_publisher_8": {"attribute_name": "出版者", "attribute_value_mlt": [{"subitem_publisher": "Hellenic Journal of Nuclear Medicine"}]}, "item_8_relation_17": {"attribute_name": "関連サイト", "attribute_value_mlt": [{"subitem_relation_name": [{"subitem_relation_name_text": "http://nuclmed.web.auth.gr/magazine/eng/may13/index.htm"}], "subitem_relation_type_id": {"subitem_relation_type_id_text": "http://nuclmed.web.auth.gr/magazine/eng/may13/index.htm", "subitem_relation_type_select": "URI"}}]}, "item_8_source_id_9": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "1790-5427", "subitem_source_identifier_type": "ISSN"}]}, "item_access_right": {"attribute_name": "アクセス権", "attribute_value_mlt": [{"subitem_access_right": "metadata only access", "subitem_access_right_uri": "http://purl.org/coar/access_right/c_14cb"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "藤林, 康久"}], "nameIdentifiers": [{"nameIdentifier": "469378", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "et.al"}], "nameIdentifiers": [{"nameIdentifier": "469379", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "藤林 康久", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "469380", "nameIdentifierScheme": "WEKO"}]}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "journal article", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "Carbon-11-acetate positron emission tomography (PET), versus fluorine-18 fluorodeoxyglucose PET and CT for the diagnosis of recurrent prostate cancer after radical prostatectomy in cases of prostate specific antigen of \u003e1 to 3ng/mL.", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "Carbon-11-acetate positron emission tomography (PET), versus fluorine-18 fluorodeoxyglucose PET and CT for the diagnosis of recurrent prostate cancer after radical prostatectomy in cases of prostate specific antigen of \u003e1 to 3ng/mL."}]}, "item_type_id": "8", "owner": "1", "path": ["1"], "permalink_uri": "https://repo.qst.go.jp/records/47015", "pubdate": {"attribute_name": "公開日", "attribute_value": "2014-12-25"}, "publish_date": "2014-12-25", "publish_status": "0", "recid": "47015", "relation": {}, "relation_version_is_last": true, "title": ["Carbon-11-acetate positron emission tomography (PET), versus fluorine-18 fluorodeoxyglucose PET and CT for the diagnosis of recurrent prostate cancer after radical prostatectomy in cases of prostate specific antigen of \u003e1 to 3ng/mL."], "weko_shared_id": -1}
Carbon-11-acetate positron emission tomography (PET), versus fluorine-18 fluorodeoxyglucose PET and CT for the diagnosis of recurrent prostate cancer after radical prostatectomy in cases of prostate specific antigen of >1 to 3ng/mL.
https://repo.qst.go.jp/records/47015
https://repo.qst.go.jp/records/4701519fcb754-736d-41ed-9712-026008db2326
Item type | 学術雑誌論文 / Journal Article(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2014-12-25 | |||||
タイトル | ||||||
タイトル | Carbon-11-acetate positron emission tomography (PET), versus fluorine-18 fluorodeoxyglucose PET and CT for the diagnosis of recurrent prostate cancer after radical prostatectomy in cases of prostate specific antigen of >1 to 3ng/mL. | |||||
言語 | ||||||
言語 | eng | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
資源タイプ | journal article | |||||
アクセス権 | ||||||
アクセス権 | metadata only access | |||||
アクセス権URI | http://purl.org/coar/access_right/c_14cb | |||||
著者 |
藤林, 康久
× 藤林, 康久× et.al× 藤林 康久 |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | Treatment of recurrent prostate cancer (PC) after radical prostatectomy is based on the site of recurrent disease [1-3]. In a previous study, we showed that carbon-11 acetate positron emission tomography (AC PET) demonstrated marked uptake in 27/46 of PC patients in recurrence after radical prostatectomy (RP), while serum PSA was higher than 3.0ng/mL [4]. In the present paper we studied 11 patients with PC following RP, who had no clinical signs of recurrence, with PSA levels of>1.0 or 1.0-3.0ng/mL and under recent hormone treatment. |
|||||
書誌情報 |
Hellenic Journal of Nuclear Medicine 巻 16, 号 2, p. 146-147, 発行日 2013-10 |
|||||
出版者 | ||||||
出版者 | Hellenic Journal of Nuclear Medicine | |||||
ISSN | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 1790-5427 | |||||
関連サイト | ||||||
識別子タイプ | URI | |||||
関連識別子 | http://nuclmed.web.auth.gr/magazine/eng/may13/index.htm | |||||
関連名称 | http://nuclmed.web.auth.gr/magazine/eng/may13/index.htm |